Abstract
Tumor interstitial fluid (TIF) surrounds and perfuses bodily tumorigenic tissues and cells, and can accumulate by-products of tumors and stromal cells in a relatively local space. Interstitial fluid offers several important advantages for biomarker and therapeutic target discovery, especially for cancer. Here, we describe the most currently accepted method for recovering TIF from tumor and nonmalignant tissues that was initially performed using breast cancer tissue. TIF recovery is achieved by passive extraction of fluid from small, surgically dissected tissue specimens in phosphate-buffered saline. We also present protocols for hematoxylin and eosin (H&E) staining of snap-frozen and formalin-fixed, paraffin-embedded (FFPE) tumor sections and for proteomic profiling of TIF and matched tumor samples by high-resolution two-dimensional gel electrophoresis (2D-PAGE) to enable comparative analysis of tumor secretome and paired tumor tissue.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Baronzio G, Parmar G, Baronzio M, Kiselevsky M (2014) Tumor interstitial fluid: proteomic determination as a possible source of biomarkers. Cancer Genomics Proteomics 11:225–237
Gromov P, Gromova I, Olsen CJ, Timmermans-Wielenga V, Talman ML, Serizawa RR, Moreira JM (2013) Tumor interstitial fluid: a treasure trove of cancer biomarkers. Biochim Biophys Acta 1834:2259–2270
Schaaij-Visser TB, de Wit M, Lam SW, Jiménez CR (2013) The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context. Biochim Biophys Acta 1834:2242–2258
Paltridge JL, Belle L, Khew-Goodall Y (2013) The secretome in cancer progression. Biochim Biophys Acta 1834(11):2233–2241
Wiig H, Tenstad O, Iversen PO, Kalluri R, Bjerkvig R (2010) Interstitial fluid: the overlooked component of the tumor microenvironment? Fibrogenesis Tissue Repair 3:12
Sylven B, Bois I (1960) Protein content and enzymatic assays of interstitial fluid from some normal tissues and transplanted mouse tumors. Cancer Res 20:831–836
Gullino PM, Clark SH, Grantham FH (1964) The interstitial fluid of solid tumors. Cancer Res 24:780–794
Aukland K, Fadness HO (1973) Protein concentration in interstitial fluid collected from rat skin by a wick method. Acta Physiol Scand 88:350–358
Stohrer M, Boucher Y, Stangassinger M, Jain RK (2000) Oncotic pressure in solid tumors is elevated. Cancer Res 60:4251–4255
Dabrosin C (2005) Microdialysis – an in vivo technique for studies of growth factors in breast cancer. Front Biosci 10:1329–1335
Huang CM, Ananthaswamy HN, Barnes S, Ma Y, Kawai M, Elmets CA (2006) Mass spectrometric proteomics profiles of in vivo tumor secretomes: capillary ultrafiltration sampling of regressive tumor masses. Proteomics 6:6107–6116
Stone MD, Odland RM, McGowan T, Onsongo G, Tang C, Rhodus NL, Jagtap P, Bandhakavi S, Griffin TJ (2010) Novel in situ collection of tumor interstitial fluid from a head and neck squamous carcinoma reveals a unique proteome with diagnostic potential. Clin Proteomics 6:75–82
Wiig H, Aukland K, Tenstad O (2003) Isolation of interstitial fluid from rat mammary tumors by a centrifugation method. Am J Physiol Heart Circ Physiol 284:H416–H424
Wiig H, Berggreen E, Borge BA, Iversen PO (2004) Demonstration of altered signaling responses in bone marrow extracellular fluid during increased hematopoiesis in rats using a centrifugation method. Am J Physiol Heart Circ Physiol 286:H2028–H2034
Semaeva E, Tenstad O, Bletsa A, Gjerde EA, Wiig H (2008) Isolation of rat trachea interstitial fluid and demonstration of local cytokine production in lipopolysaccharide-induced systemic inflammation. J Appl Physiol 104:809–820
Brekke HK, Oveland E, Kolmannskog O, Hammersborg SM, Wiig H, Husby P, Tenstad O, Nedrebø T (2010) Isolation of interstitial fluid in skin during volume expansion: evaluation of a method in pigs. Am J Physiol Heart Circ Physiol 299:H1546–H1553
Haslene-Hox H, Oveland E, Berg KC, Kolmannskog O, Woie K, Salvesen HB, Tenstad O, Wiig H (2011) A new method for isolation of interstitial fluid from human solid tumors applied to proteomic analysis of ovarian carcinoma tissue. PLoS One 6, e19217
Celis JE, Gromov P, Cabezón T, Moreira JM, Ambartsumian N, Sandelin K, Rank F, Gromova I (2004) Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery. Mol Cell Proteomics 3:327–344
Celis JE, Moreira JM, Cabezón T, Gromov P, Friis E, Rank F, Gromova I (2005) Identification of extracellular and intracellular signaling components of the mammary adipose tissue and its interstitial fluid in high risk breast cancer patients: toward dissecting the molecular circuitry of epithelial-adipocyte stromal cell interactions. Mol Cell Proteomics 4:492–522
Gromov P, Moreira JM, Gromova I, Celis JE (2008) Proteomic strategies in bladder cancer: from tissue to fluid and back. Proteomics Clin Appl 2:974–988
Teng PN, Hood BL, Sun M, Flint MS, Bateman NW, Dhir R, Bhargava R, Richard SD, Edwards RP, Conrads TP (2010) Differential proteomic analysis of renal cell carcinoma tissue interstitial fluid. J Proteome Res 10:1333–1342
Sun W, Ma J, Wu S (2010) Characterization of the liver tissue interstitial fluid (TIF) proteome indicates potential for application in liver disease biomarker discovery. J Proteome Res 9:1020–1031
Wang TH, Chao A, Tsai CL, Chang CL, Chen SH, Lee YS, Chen JK, Lin YJ, Chang PY, Wang CJ, Chao AS, Chang SD, Chang TC, Lai CH, Wang HS (2010) Stress-induced phosphoprotein 1 as a secreted biomarker for human ovarian cancer promotes cancer cell proliferation. Mol Cell Proteomics 9:1873–1884
Gromova II, Celis JE (2006) Protein detection in gels by silver staining: a procedure compatible with mass spectrometry. In: Celis JE, Carter N, Hunter T, Simons K, Small JV, Shotton D (eds) A cell biology. Laboratory handbook, 3rd edn. Elsevier, New York, NY, pp 219–223
Rogowska-Wrzesinska A, Le Bihan MC, Thaysen-Andersen M, Roepstorff P (2013) 2D gels still have a niche in proteomics. J Proteomics 88:4–13
Oliveira BM, Coorssen JR, Martins-de-Souza D (2014) 2DE: the phoenix of proteomics. J Proteomics 104:140–150
Teng PN, Rungruang BJ, Hood BL (2010) Assessment of buffer systems for harvesting proteins from tissue interstitial fluid for proteomic analysis. J Proteome Res 9:4161–4169
Gromov P, Gromova I, Bunkenborg J, Cabezon T, Moreira JM, Timmermans-Wielenga V, Roepstorff P, Rank F, Celis JE (2010 Feb) Up-regulated proteins in the fluid bathing the tumour cell microenvironment as potential serological markers for early detection of cancer of the breast. Mol Oncol 4(1):65–89. doi:10.1016/j.molonc.2009.11.003, Epub 2009 Nov 23
Celis JE, Moreira JMA, Gromov P (2006) Determination of antibody specificity by western blotting. In: Celis JE, Carter N, Hunter T, Simons K, Small JV, Shotton D (eds) A cell biology. Laboratory handbook, 3rd edn. Elsevier, New York, NY, pp 527–532
Acknowledgements
Preparation of this manuscript was supported by the Danish Cancer Society through the Danish Cancer Society Research Center budget and by grants from the John and Birthe Meyer Foundation and EurocanPlatform.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Gromov, P., Gromova, I. (2016). Characterization of the Tumor Secretome from Tumor Interstitial Fluid (TIF). In: Pompa, A., De Marchis, F. (eds) Unconventional Protein Secretion. Methods in Molecular Biology, vol 1459. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3804-9_16
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3804-9_16
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3802-5
Online ISBN: 978-1-4939-3804-9
eBook Packages: Springer Protocols